Avanos Medical to be Acquired by American Industrial Partners for $1.272 Billion in All-Cash Deal
Summary
Avanos Medical, Inc. has entered into a definitive agreement to be acquired by American Industrial Partners for approximately $1.272 billion, with stockholders receiving $25.00 per share in cash.
Key Events
-
Definitive Merger Agreement Signed
Avanos Medical, Inc. entered into an Agreement and Plan of Merger with A-AV Holdco I, Inc. and A-AV MergerSub, Inc., affiliates of American Industrial Partners, on April 13, 2026.
-
Acquisition Price Set at Significant Premium
Each outstanding share of common stock will be converted into the right to receive $25.00 in cash, without interest. This represents a 72.1% premium to the closing stock price on April 13, 2026, and an 82.8% premium to the 30-day volume-weighted average share price.
-
Board Unanimously Approved Transaction
Avanos' Board of Directors unanimously determined the merger agreement and transactions are advisable, fair, and in the best interests of the company and its stockholders, recommending approval to shareholders.
-
Company to Go Private and Delist
Upon completion, Avanos will become a private company, and its common stock will be delisted from the New York Stock Exchange and deregistered under the Securities Exchange Act of 1934.
Analysis
Avanos Medical, Inc. has entered into a definitive merger agreement to be acquired by American Industrial Partners, a private equity firm. This all-cash transaction values Avanos at approximately $1.272 billion, with stockholders receiving $25.00 per share. This represents a substantial premium of 72.1% over the prior day's closing price, indicating a significant value unlock for shareholders. The acquisition will take Avanos private, delisting its common stock from the NYSE, and is expected to close in the second half of 2026, subject to shareholder and regulatory approvals. This event fundamentally alters the investment thesis for Avanos, shifting focus from operational performance to the successful completion of the acquisition.
At the time of this filing, AVNS was trading at $24.44 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $675.8M. The 52-week trading range was $9.30 to $15.68. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.